The Enterprise Value as of December 2024 (TTM) for Predictive Oncology Inc. (POAI) is 4.29M

According to Predictive Oncology Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.29M. This represents a change of -16.90% compared to the average of 5.16M of the last 4 quarters.

Predictive Oncology Inc. (POAI) Historical Enterprise Value (quarterly & annually)

How has POAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Predictive Oncology Inc. over the last ten years is 11.22M. The current 4.29M Enterprise Value has changed 3.72% with respect to the historical average. Over the past ten years (40 quarters), POAI's Enterprise Value was at its highest in in the December 2021 quarter at 1.22B. The Enterprise Value was at its lowest in in the June 2022 quarter at 533.31K.

Predictive Oncology Inc. (POAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Predictive Oncology Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Predictive Oncology Inc. (POAI) Average Enterprise Value

How has POAI Enterprise Value performed in the past?

The current Enterprise Value of Predictive Oncology Inc. (POAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Predictive Oncology Inc. (POAI) Enterprise Value vs. Peers

How is POAI’s Enterprise Value compared to its peers?

Predictive Oncology Inc.’s Enterprise Value is less than GlucoTrack, Inc. (6.05M), greater than G Medical Innovations Holdings Ltd (3.60M), greater than Sharps Technology, Inc. (3.47M), less than Microbot Medical Inc. (16.50M), less than NEXGEL, Inc. (34.39M), less than Pro-Dex, Inc. (168.34M), less than Innovative Eyewear, Inc. (9.43M), less than Jin Medical International Ltd. (154.49M), less than Bionano Genomics, Inc. (34.30M), less than Intuitive Surgical, Inc. (188.86B), less than Stereotaxis, Inc. (192.89M), less than Nyxoah S.A. (258.17M), less than Daxor Corporation (40.10M), less than Milestone Scientific Inc. (60.97M),

Build a custom stock screener for Predictive Oncology Inc. (POAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Predictive Oncology Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Predictive Oncology Inc. (POAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Predictive Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.